Petros Pharmaceuticals Inc (PTPI) concluded trading on Wednesday at a closing price of $1.60, with 4.72 million shares of worth about $7.55 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -50.00% during that period and on Wednesday the price saw a gain of about 3.90%. Currently the company’s common shares owned by public are about 2.08M shares, out of which, 1.29M shares are available for trading.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 5 times over the past 12 months. They bought 74,517 shares in 5 of the transactions. In 0 selling transactions, insiders dumped 0 shares.
Stock saw a price change of 41.59% in past 5 days and over the past one month there was a price change of 31.15%. Year-to-date (YTD), PTPI shares are showing a performance of 13.48% which decreased to -38.46% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.92 but also hit the highest price of $9.54 during that period. The average intraday trading volume for Petros Pharmaceuticals Inc shares is 730.04K. The stock is currently trading 31.77% above its 20-day simple moving average (SMA20), while that difference is up 21.92% for SMA50 and it goes to -26.63% lower than SMA200.
Petros Pharmaceuticals Inc (NASDAQ: PTPI) currently have 2.08M outstanding shares and institutions hold larger chunk of about 5.98% of that.
The stock has a current market capitalization of $3.52M and its 3Y-monthly beta is at 2.15. It has posted earnings per share of -$6.21 in the same period. It has Quick Ratio of 2.71 while making debt-to-equity ratio of 1.23. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for PTPI, volatility over the week remained 26.22% while standing at 20.06% over the month.
Analysts are in expectations that Petros Pharmaceuticals Inc (PTPI) stock would likely to be making an EPS of -$1.11 in the current quarter, while forecast for next quarter EPS is -$1.19 and it is -$5.01 for next year. For the current quarter EPS, analysts have given the company a lowest target -$1.11 which is -$1.11 at the higher side of the target for the same.
